Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

H ealth officials in the UK are launching an investigation into weight loss drugs after hundreds of consumers reported ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

CVS is set to drop Zepbound as a medicine, but will continue to carry other popular weight loss drugs instead.

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

The country’s Medicines and Healthcare products Regulatory Agency’s Yellow Card scheme, the UK’s official system for ...

Researchers say GLP-1 medicines might be able to help with migraines.

The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

The two largest health insurers in Massachusetts are effectively telling the drug companies that they may seek a rapidly ...